<DOC>
	<DOCNO>NCT01362127</DOCNO>
	<brief_summary>The purpose randomize study clarify neoadjuvant radiochemotherapy give high degree complete histological response neoadjuvant chemotherapy surgery patient undergoing treatment cancer esophagus cardia .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy Versus Radiochemotherapy Cancer Esophagus Cardia</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically verify squamos cell carcinoma , adenocarcinoma esopohagus gastric cardia ( type II ) Tumor locate cervical oesophagus , require laryngoesophagectomy . Patients performance status 01 axxording WHO scale resectable tumour , assess prerandomisation evaluation Adequate haemotological function , define WBC &gt; 3 x 10 ( 9 ) /litre platelet &gt; 100 x 10 ( 9 ) /litre . Adequate renal function define normal serum creatinine level and/or calculate glomerular filtration rate &gt; 60 ml/min . Tumour stage : T1Ni , T2N0 , T2N1 , T3N0 , T3N1 , M1a Pregnancy and/or lactation . Women childbearing age include provided adequate contraceptive method use Patients diabetes complication ( e.g . rethinopathy , neuropathy ) well patient uncontrolled cardiac disease myocard infarction within 12 month consider unsuitable chemoradiotherapy . Concomitant malignancy ( &lt; 5 year since diagnosis ) interfere interpretation study result , ongoing antitumoral treatment . Patients unable tom comply protocol Tumor stage T1 N0 , T4 NX TXNXM1b</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Histologically confirm squamos cell carcinoma adenocarcinoma esophagus gastric cardia.Suitable surgery .</keyword>
</DOC>